Interferon-gamma antagonizes transforming growth factor-beta2-mediated immunosuppression in murine Toxoplasma encephalitis. (Q48498630)

12 February 2018

title

Interferon-gamma antagonizes transforming growth factor-beta2-mediated immunosuppression in murine Toxoplasma encephalitis. (English)

1 reference

12 February 2018

1 reference

Schlüter D

1

1 reference

12 February 2018

Bertsch D

2

1 reference

12 February 2018

Frei K

3

1 reference

12 February 2018

Hübers SB

4

1 reference

12 February 2018

Wiestler OD

5

1 reference

12 February 2018

Hof H

6

1 reference

12 February 2018

Fontana A

7

1 reference

12 February 2018

Deckert-Schlüter M

8

1 reference

12 February 2018

publication date

1 January 1998

1 reference

12 February 2018

Journal of Neuroimmunology

published in

1 reference

12 February 2018

volume

81

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

38-48

1 reference

12 February 2018

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Beta transforming growth factors are potential regulators of B lymphopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Systemic immunization induces protective CD4+ and CD8+ T cell-mediated immune responses in murine Listeria monocytogenes meningoencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900156-2

7 January 2021

10.1016/S0165-5728(97)00156-2

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9521604

1 reference

12 February 2018